August 14, 2025

Low-density lipoprotein cholesterol and cardiovascular risk in the absence of calcifications on computed tomography: the Western Denmark Heart Registry

MAMalene Højgaard AndersenAarhus University JJJesper Møller JensenCardiac Imaging HKHelle KanstrupAarhus University

Key Points

Elevated LDL cholesterol increases risk of non-calcified plaques and coronary heart disease events in individuals with zero coronary calcification.
For each 1 mmol/L rise in LDL cholesterol, the adjusted odds ratio for non-calcified plaques increases by 1.21.
Assessments were conducted using coronary computed tomography angiography across 23,777 symptomatic individuals over a median follow-up of 7.1 years.
These findings stress the importance of managing LDL cholesterol levels in younger individuals regardless of coronary calcification status.

Abstract

Abstract Aims Coronary atherosclerosis tends to be non-calcified at early stages, questioning the implications of a coronary artery calcification score of zero (CAC = 0) at younger ages. This study investigates whether elevated low-density lipoprotein cholesterol (LDL-C) is associated with the presence of non-calcified plaques and future cardiovascular events in individuals with CAC = 0 across different ages. Methods and results This cohort study from the Western Denmark Heart Registry included symptomatic individuals undergoing coronary computed tomography angiography (CCTA) from 2008–2021, with a 7.1-year median follow-up time. Outcomes included adjusted odds ratios (aOR) for non-calcified plaque on CCTA and adjusted hazard ratios (aHR) for coronary heart disease (CHD). The study included 23 777 individuals with CAC = 0. Median age was 54 (Q1–Q3 47–61) years, and 61% were women. The prevalence of non-calcified plaques was 11%. Per 1 mmol/L higher LDL-C, the overall aOR for non-calcified plaques was 1.21 95% confidence interval (CI) 1.16–1.27; corresponding values were 1.39 (1.23–1.56) at age ≤45, 1.22 (1.14–1.31) at age 46–60, and 1.11 (1.02–1.21) at age 60. During follow-up, 299 (1%) had a CHD event. Per 1 mmol/L higher LDL-C, the overall aHR was 1.28 (1.13–1.46) for CHD; corresponding values were 1.37 (1.04–1.82) at age ≤45, 1.24 (1.04–1.49) at age 46–60, and 1.26 (1.00–1.60) at age 60. Conclusion In symptomatic individuals with CAC = 0, elevated LDL-C is associated with higher risk of non-calcified plaque and with higher relative risk of future CHD events, most pronounced at age ≤45 years. This indicates that LDL-C control over a long-time horizon remains important in younger individuals despite CAC = 0.

Ask AI

Helpful

Bookmark

View Full Paper